Advanced isolated light chain amyloid cardiomyopathy with negative immunofixation and normal free li...
Advanced isolated light chain amyloid cardiomyopathy with negative immunofixation and normal free light chain ratio
About this item
Full title
Author / Creator
Publisher
England: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
England: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
Amyloid light chain (AL) cardiomyopathy is the most malignant specific cardiomyopathy. According to international recommendations, it should be ruled out non‐invasively using the serum free light chain (FLC) ratio and immunofixation electrophoresis in both serum and urine. Here, we report on a 69‐year‐old female patient with new‐onset heart failure...
Alternative Titles
Full title
Advanced isolated light chain amyloid cardiomyopathy with negative immunofixation and normal free light chain ratio
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_9e1d8438218b4f629a25a241ec26c276
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9e1d8438218b4f629a25a241ec26c276
Other Identifiers
ISSN
2055-5822
E-ISSN
2055-5822
DOI
10.1002/ehf2.13381
